Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Ovarian Cancer Health Center

Font Size

Blood Test May Spot Inherited Ovarian Cancer

Study Shows Gene Test May Be Able to Identify Women at Risk for Ovarian Cancer
WebMD Health News
Reviewed by Laura J. Martin, MD

March 9, 2011 (Orlando, Fla.) -- Nearly one in four ovarian cancers are inherited, say researchers who are developing a gene-based blood test to identify women with these hereditary cancers.

The test, which looks for variations in 22 genes known or suspected to predispose women to ovarian cancer, isn't ready for prime time yet.

But if results of the new study can be replicated and the test becomes commercially available, it would be a big advance over the current genetic screen, says study head Elizabeth Swisher, MD, an expert in medical genetics at the University of Washington in Seattle.

The current test, which screens for the BRCA1 and BRCA2 genes, only spots about 10% to 15% of ovarian cancers, she tells WebMD.

The new study included 284 women who were undergoing surgery to remove an ovarian or fallopian tube tumor. All provided blood samples for DNA testing.

A total of 24% had a mutation in one or more of the 22 genes, which included BRCA 1 and BRCA2.

About three-fourths of women who tested positive for a mutation had a family history of breast or ovarian cancer. (The same genes that increase a woman's risk of ovarian cancer are usually associated with increased breast cancer risk, too.)

The results were presented at the Society of Gynecologic Oncology's Annual Meeting on Women's Cancer.

Family Testing

If the test does become available, who should be tested?

"If there is a family history of ovarian or breast cancer, the woman with cancer should ideally be tested first," Swisher says.

Then if she does test positive for the cancer, her daughter or other close female relatives may want to consider testing too, she says.

Swisher says she expects the new test to cost about $1,000. That’s cheaper than the BRCA1/2 test, which costs $4,000.

Jonathan M. Lancaster, MD, PhD, of the H. Lee Moffitt Cancer Center in Tampa, Fla., tells WebMD that the new research "contributes to our goal of personalized medicine."

But there's still a long way to go, he says, noting that gene-based cancer blood screens that look good in early testing don't always hold up to scrutiny.

Today on WebMD

Ovarian cancer illustration
What are the symptoms?
doctory with x-ray
Get to know the Symptoms.
cancer cell
HPV is the top cause. Find out more.
Lung cancer xray
See it in pictures, plus read the facts.
Integrative Medicine Cancer Quiz
Lifestyle Tips for Depression Slideshow
Screening Tests for Women
Graphic of ovaries within reproductive system
Ovarian Cancer Marker
Pets Improve Your Health
Vitamin D
Healthy meal with salmon